Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if spironolactone, a drug that blocks the action of
aldosterone, can make the blood vessels work better in people with obesity. The investigators
also want to find out whether spironolactone causes changes in levels of insulin and markers
of inflammation.